New coworking space to open, Houston to host Accenture's health tech awards, and more innovation news

Short stories

Spaces plans to open a new location in Houston this month, Chevron Technology Ventures invests in autonomous vehicle tech, and more Houston innovation news. Courtesy of Spaces

A lot is happening in the Houston innovation ecosystem — so much that you may have missed a few key news items. Let's hit the highlights, shall we?

Applications are open for major health tech awards program that is coming to town, a Houston corporate venture fund doles out cash to self-driving cars, new coworking space to deliver, a diversity-focused partnership launches, and more Houston innovation news.

Chevron Technology Ventures invests in self-driving cars

Voyage is growing its fleet of self-driving vehicles with the help of a Houston corporate VC fund. Photo via voyage.auto

Silicon Valley's Voyage, a self-driving car technology company, closed its series B round at $31 million. Houston-based Chevron Technology Ventures contributed to the round.

The round's funds will go toward expanding the company's fleet of G2 autonomous vehicles in California and Florida, as well as introduce Voyage's G3 self-driving car, Oliver Cameron, co-founder and CEO at Voyage, writes in a release.

"Chevron has been supporting the public's transportation needs for over 100 years. As our customers' mobility needs and preferences change, we want to continue to be part of their journeys. Our investment in Voyage affirms this commitment," says Barbara Burger, CTV president, in a release. "We established the Future Energy Fund in 2018 with an initial commitment of $100 million to invest in breakthrough technologies that enable the ongoing energy transition. The fund looks for technologies that lower emissions and support low carbon value chains. Our investment in Voyage fits well within the objectives of the Future Energy Fund while also informing our perspective on the changing energy landscape."

Accenture to close out health tech challenge in Houston

accenture

The national challenge will conclude in Houston. Courtesy of Accenture

Applications are open for the fourth annual Accenture HealthTech Innovation Challenge and close on September 22. Finalists will present to judges from global health companies at one of two regional events — in Boston on Nov. 7 or in San Francisco on Dec. 5. The final judging event will take place in Houston on February 6, 2020.

"We look forward to this year's submissions as we continue to identify bold ideas from startups that deliver new solutions for health organizations to improve the lives of consumers, clinicians and employees," says Brian Kalis, managing director of digital health and innovation at Accenture, in a release. "Since its inception, the Accenture HealthTech Innovation Challenge has brought healthcare organizations and startups together to tackle the world's biggest health issues where we have received more than 2,200 applications, invited more than 90 startups to compete and who have benefitted from the guidance of nearly 1,000 executive judges from the healthcare industry."

The submission form, including additional details about the challenge's criteria, eligibility, and requirements, is available at: Accenture HealthTech Innovation Challenge-Health.

GotSpot wins pitch competition

Reda Hicks claimed the win at a military spouse pitch event. Trish Alegre-Smith/Military.com

Reda Hicks, who founded Houston-based GotSpot Inc., won a $15,000 check from the StreetShares Foundation and Samuel Adams' Brewing the American Dream at the Great American Military Entrepreneur at the Military Influencer Conference in Washington, D.C.

GotSpot is a website that allows for people with commercial space — a commercial kitchen, conference room, spare desks, etc. — to list it. Then, space seekers — entrepreneurs, nonprofits, freelancers, etc. — can rent it.

"This award is a game-changer for me," Hicks says to Military.com. "This will allow me to hire more incredible military spouses and help GotSpot on its path to go global."

Rice University launches new sports business course

Rice University

Rice University has a new sports business program. Photo courtesy of Rice University

Rice University, along with the Houston Texans, is introducing a new program for the university's sport management students. Pro Sports: Management is a course designed to teach the business side of the sports world.

"We are thrilled to partner with Rice University on a curriculum that will provide their best and brightest students with insight into the real-world opportunities and challenges facing today's sports teams," says Houston Texans President Jamey Rootes in a release from Rice. "This program is rather unique because our leading executives will work alongside Rice professors to teach current best practices in franchise management across every discipline. We believe that this type of practical industry exposure is the best way to prepare the next generation of leaders in the field of sports management and a valuable contribution to the level of professionalism within our industry."

The classes will be held weekly in the executive offices of the Texans. The course will cover ticketing, public relations, event management, human resources and more.

Spaces plans to open second coworking location in Houston

Spaces, an Amsterdam-based coworking space company that entered the Houston market with a lease in Kirby Grove announced in 2017, plans to open its newest location this month. Courtesy of Spaces

The new Spaces CityCentre One location is planned to open on Monday, September 30. It's the Amsterdam-based company's second coworking space in Houston, with a third already in the works. The first location was in Kirby Grove in 2017, and Spaces Galleria at Post Oak will be opening in the second quarter of 2020.

The CityCentre One location will have over 60,000 square-feet of workspace with perks, including a business club, dedicated desk space, private offices, and seven fully-equipped meeting rooms. Plus, the building is just steps away from CityCentre, a mixed-use development with restaurants, entertainment, housing, and more. Membership pricing starts at $111 a month at the new location.

Cemvita Factory receives more backing from oil and gas industry

Cemvita FactoryCemvita Factory

Houston-based Cemvita Factory, a biotech company that can mimick photosynthesis and convert CO2 into glucose and other substances, has received equity investment from BHP. The amount of the investment was not disclosed.

The investment will help Cemvita Factory continue to develop its biomimicry technology for oil and gas applications to reduce the volume of greenhouse gas emissions.

"This strategic investment fits well with BHP's vision of the future: reducing operational greenhouse gas emissions, reducing environmental impact and the development of low-emissions technology, including increased application of carbon capture, utilization and storage technology," says BHP's chief geoscientist, Laura Tyler, in a release.

Last month, Occidental Petroleum's low carbon subsidiary, Oxy Low Carbon Ventures LLC, announced it invested an undisclosed amount of funds into Cemvita Factory.

Two organizations join forces to promote diversity in the Houston Startup Scene

Impact Hub Houston and The Cannon have teamed up to grow programming and events surrounding diversity. Photo courtesy of The Cannon

In an effort to promote diversity and inclusion within the Houston innovation ecosystem, The Cannon and Impact Hub Houston have teamed up. The collaboration will drive programming and events geared at growing the conversation and resources for startups and entrepreneurs.

"One of Houston's best differentiating qualities is that we are truly a melting pot," says Lawson Gow, founder and CEO of The Cannon, in a news release. "We want our community to reflect the amazing diversity across our city, so we have to move beyond simply discussing diversity and work to create an environment where innovation can thrive and real change can happen. We are confident Impact Hub will be the perfect partner to bring those aspects to our community."

Gow, who is the son of InnovationMap's parent company's CEO, opened the doors to its new 120,000-square-foot facility in July. Impact Hub Houston will have a presence in the space.

"Over the past few years, Lawson and I have brainstormed how we could work together to connect and grow our region's innovation ecosystem and demonstrate how organizations can evolve from competition to true collaboration," says Grace Rodriguez, CEO and Executive Director of Impact Hub Houston, in the release. "I'm so excited that those talks have developed into this partnership: Through The Cannon and Impact Hub Houston, we'll be able to effectively 'meet people where they are' geographically, socially, and culturally, helping diverse entrepreneurs and startups at the myriad intersections of place, purpose, demographics, psychographics, and business growth stages."

Houston innovator nominated for prestigious Silicon Valley award

Alley Lyles is up for an award for her work in digital transformation.

Alley Lyles, digital transformation manager at Direct Energy and Houston startup mentor, was nominated for a Women in IT - Silicon Valley award as Transformation Leader of the Year. The awards event is on October 9.

She is up against Emily Dunn at Anaplan, Windy Garrett at Atos, Manju Abraham at Delphix, Aashima Gupta at Google, Patricia Grant at ServiceNow, and Nataliya Anon at Svitla Systems.

"I am proud to represent Houston in Silicon Valley. The Houston hustle is real. I see it amongst my colleagues who got me here. The hustle isn't always glamorous, so I appreciate the moment when a kid from the East End can shine."

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Intuitive Machines forms partnership with Italian companies for lunar exploration services

to the moon

Houston-based space technology, infrastructure and services company Intuitive Machines has forged a partnership with two Italian companies to offer infrastructure, communication and navigation services for exploration of the moon.

Intuitive Machines’ agreement with the two companies, Leonardo and Telespazio, paves the way for collaboration on satellite services for NASA, a customer of Intuitive Machines, and the European Space Agency, a customer of Leonardo and Telespazio. Leonardo, an aerospace, defense and security company, is the majority owner of Telespazio, a provider of satellite technology and services.

“Resilient, secure, and scalable space infrastructure and space data networks are vital to customers who want to push farther on the lunar surface and beyond to Mars,” Steve Altemus, co-founder and CEO of Intuitive Machine, said in a news release.

Massimo Claudio Comparini, managing director of Leonardo’s space division, added that the partnership with Intuitive Machines is a big step toward enabling human and robotic missions from the U.S., Europe and other places “to access a robust communications network and high-precision navigation services while operating in the lunar environment.”

Intuitive Machines recently expanded its Houston Spaceport facilities to ramp up in-house production of satellites. The company’s first satellite will launch with its upcoming IM‑3 lunar mission.

Intuitive Machines says it ultimately wants to establish a “center of space excellence” at Houston Spaceport to support missions to the moon, Mars and the region between Earth and the moon.

Houston hospitals win $50M grant for ibogaine addiction treatment research

ibogaine funding

The Texas Health and Human Services Commission has awarded $50 million to UTHealth Houston in collaboration with The University of Texas Medical Branch at Galveston (UTMB Health) to co-lead a multicenter research trial to evaluate the effect of ibogaine, a powerful psychoactive compound, on patients suffering from addiction, traumatic brain injury and other behavioral health conditions.

The funding will establish a two-year initiative—known as Ibogaine Medicine for PTSD, Addiction, and Cognitive Trauma (IMPACT)—and a consortium of Texas health institutions focused on clinical trials and working toward potential FDA-approved treatments.

The consoritum will also include Texas Tech University, Texas Tech University Health Sciences Center El Paso, The University of Texas at Austin, The University of Texas Health Science Center at San Antonio, The University of Texas at Tyler, The University of Texas Rio Grande Valley, Texas A&M University, The University of North Texas Health Science Center, Baylor College of Medicine and JPS Health Network in Dallas.

Ibogaine is a plant-based, psychoactive substance derived from the iboga shrub. Research suggests that the substance could be used for potential treatment for patients with traumatic brain injuries, which is a leading cause of post-traumatic stress disorders. Ibogaine has also shown potential as a treatment for addiction and other neurological conditions.

UTHealth and partners will focus on ways that ibogaine can treat addiction and associated conditions. Meanwhile, UT Austin and Baylor College of Medicine will concentrate on using it to treat traumatic brain injury, especially in veterans, according to a news release from the institutions.

The consortium will also support drug developers and teaching hospitals to conduct FDA-approved clinical trials. The Texas Health and Human Services Commission will oversee the grant program.

“This landmark clinical trial reflects our unwavering commitment to advancing research that improves lives and delivers the highest standards of care,” Dr. Melina Kibbe, UTHealth Houston president and the Alkek-Williams Distinguished Chair, said in the news release. “By joining forces with outstanding partners across our state, we are building on Texas’ tradition of innovation to ensure patients struggling with addiction and behavioral health conditions have access to the best possible outcomes. Together, we are shaping discoveries that will serve Texans and set a model for the nation.”

The consortium was authorized by the passage of Senate Bill 2308. The bill provides $50 million in state-matching funds for an ibogaine clinical trial managed by a public university in partnership with a drug company and a hospital.

“This is the first major step towards the legislature’s goal of obtaining FDA approval through clinical trials of ibogaine — a potential breakthrough medication that has brought thousands of America’s war-fighters back from the darkest parts of depression, anxiety, PTSD, and chronic addiction,” Texas Rep. Cody Harris added in the release. “I am excited to walk alongside UTHealth Houston and UTMB as these stellar institutions lead the nation in a first-of-its-kind clinical trial in the U.S.”

Recently, the University of Houston also received a $2.6 million gift from the estate of Dr. William A. Gibson to support and expand its opioid addiction research, which includes the development of a fentanyl vaccine that could block the drug's ability to enter the brain. Read more here.

Tesla no longer world's biggest EV maker as sales fall for second year

Tesla Talk

Tesla lost its crown as the world’s bestselling electric vehicle maker as a customer revolt over Elon Musk’s right-wing politics, expiring U.S. tax breaks for buyers and stiff overseas competition pushed sales down for a second year in a row.

Tesla said that it delivered 1.64 million vehicles in 2025, down 9% from a year earlier.

Chinese rival BYD, which sold 2.26 million vehicles last year, is now the biggest EV maker.

It's a stunning reversal for a car company whose rise once seemed unstoppable as it overtook traditional automakers with far more resources and helped make Musk the world's richest man. The sales drop came despite President Donald Trump's marketing effort early last year when he called a press conference to praise Musk as a “patriot” in front of Teslas lined up on the White House driveway, then announced he would be buying one, bucking presidential precedent to not endorse private company products.

For the fourth quarter, Tesla sales totaled 418,227, falling short of even the much reduced 440,000 target that analysts recently polled by FactSet had expected. Sales were hit hard by the expiration of a $7,500 tax credit for electric vehicle purchases that was phased out by the Trump administration at the end of September.

Tesla stock fell 2.6% to $438.07 on Friday.

Even with multiple issues buffeting the company, investors are betting that Tesla CEO Musk can deliver on his ambitions to make Tesla a leader in robotaxi services and get consumers to embrace humanoid robots that can perform basic tasks in homes and offices. Reflecting that optimism, the stock finished 2025 with a gain of approximately 11%.

The latest quarter was the first with sales of stripped-down versions of the Model Y and Model 3 that Musk unveiled in early October as part of an effort to revive sales. The new Model Y costs just under $40,000 while customers can buy the cheaper Model 3 for under $37,000. Those versions are expected to help Tesla compete with Chinese models in Europe and Asia.

For fourth-quarter earnings coming out in late January, analysts are expecting the company to post a 3% drop in sales and a nearly 40% drop in earnings per share, according to FactSet. Analysts expect the downward trend in sales and profits to eventually reverse itself as 2026 rolls along.

Musk said earlier last year that a “major rebound” in sales was underway, but investors were unruffled when that didn't pan out, choosing instead to focus on Musk's pivot to different parts of business. He has has been saying the future of the company lies with its driverless robotaxis service, its energy storage business and building robots for the home and factory — and much less with car sales.

Tesla started rolling out its robotaxi service in Austin in June, first with safety monitors in the cars to take over in case of trouble, then testing without them. The company hopes to roll out the service in several cities this year.

To do that successfully, it needs to take on rival Waymo, which has been operating autonomous taxis for years and has far more customers. It also will also have to contend with regulatory challenges. The company is under several federal safety investigations and other probes. In California, Tesla is at risk of temporarily losing its license to sell cars in the state after a judge there ruled it had misled customers about their safety.

“Regulatory is going to be a big issue,” said Wedbush Securities analyst Dan Ives, a well-known bull on the stock. “We're dealing with people's lives.”

Still, Ives said he expects Tesla's autonomous offerings will soon overcome any setbacks.

Musk has said he hopes software updates to his cars will enable hundreds of thousands of Tesla vehicles to operate autonomously with zero human intervention by the end of this year. The company is also planning to begin production of its AI-powered Cybercab with no steering wheel or pedals in 2026.

To keep Musk focused on the company, Tesla’s directors awarded Musk a potentially enormous new pay package that shareholders backed at the annual meeting in November.

Musk scored another huge windfall two weeks ago when the Delaware Supreme Court reversed a decision that deprived him of a $55 billion pay package that Tesla doled out in 2018.

Musk could become the world's first trillionaire later this year when he sells shares of his rocket company SpaceX to the public for the first time in what analysts expect would be a blockbuster initial public offering.

View All Listings